文献速递肝病

富含半胱氨酸蛋白61的功能特征:调控肝脏炎症中髓源性抑制细胞

A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.
PubMed 文献 · Hepatology · 2017-11-17

研究纳入148例肝炎症患者和45例健康对照,分析髓源性抑制细胞(MDSC)的频率、表型和功能;发现HLA-DR-/low CD33+ CD11b+ CD14+ CD15-单核细胞型MDSC在肝炎症疾病中升高,且在原发性胆汁性胆管炎(PBC)中与碱性磷酸酶、总胆红素相关;CCN1调控MDSC扩增和诱导型一氧化氮合酶相关免疫抑制。

要点

  • 肝炎症疾病患者外周血单核细胞型MDSC较健康对照升高。
  • PBC中循环MDSC水平与碱性磷酸酶、总胆红素显著相关。
  • CCN1调控MDSC扩增及诱导型一氧化氮合酶相关免疫抑制功能。

核心结论

  • CCN1调控MDSC的扩增和抑制功能,数据提示CCN1对MDSC的潜在作用及在炎症性肝病中的治疗意义。

研究设计与样本

  • 研究纳入148例肝炎症患者和45例健康对照,其中外周血分析队列包括55例PBC、40例自身免疫性肝炎、39例慢性乙型肝炎、14例非酒精性脂肪性肝病和45例健康对照,肝脏靶向检测包括27例PBC、27例自身免疫性肝炎、20例慢性乙型肝炎、14例非酒精性脂肪性肝病和6例对照。

主要发现

  • HLA-DR-/low CD33+ CD11b+ CD14+ CD15-单核细胞型MDSC在肝炎症疾病中较健康对照升高。
  • PBC中循环MDSC水平与疾病相关生化标志物碱性磷酸酶、总胆红素显著相关。
  • 对熊去氧胆酸应答的PBC患者MDSC水平较高。
  • PBC来源的MDSC表现出强效免疫抑制功能。
  • PBC炎症病变中肝脏MDSC积聚与组织学改变如纤维化显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: There is increasing awareness of the immunologic roles of liver mononuclear populations, including myeloid-derived suppressor cells (MDSCs). We took advantage of a large well-defined cohort of 148 patients with liver inflammation and 45 healthy controls to focus on the qualitative and quantitative characteristics of MDSCs. We investigated the frequency, phenotype, and functional capacities of MDSCs by using peripheral blood MDSCs in a cohort of 55 patients with primary biliary cholangitis (PBC), 40 with autoimmune hepatitis, 39 with chronic hepatitis B, 14 with nonalcoholic fatty liver disease, and 45 healthy controls. This was followed by a liver-targeted determination in 27 patients with PBC, 27 with autoimmune hepatitis, 20 with chronic hepatitis B, 14 with nonalcoholic fatty liver disease, and 6 controls. We then focused on mechanisms of this expansion with PBC as an example, using both ursodeoxycholic acid-naive and treated patients. HLA-DR-/low CD33+ CD11b+ CD14+ CD15- monocytic MDSCs were elevated in diseases characterized by liver inflammation compared to healthy controls. Using PBC as a focus, there was a significant correlation between levels of circulating MDSCs and disease-related biochemical markers (alkaline phosphatase, total bilirubin). We found higher amounts of MDSCs in patients with PBC who were responsive to ursodeoxycholic acid. MDSCs from PBC were found to manifest a potent immunosuppressive function. There was a significant correlation in the accumulation of hepatic MDSCs in the inflamed lesions of PBC with histologic changes, such as fibrosis. We also found that cysteine-rich protein 61 (CCN1), a highly expressed protein in impaired cholangiocytes and hepatocytes, contributes to MDSC expansion and MDSC inducible nitric oxide synthase-associated immune suppression. CONCLUSION: CCN1 modulates expansion and a suppressive function of MDSCs. Our data highlight the potential functions of CCN1 on MDSCs and suggest therapeutic implications in inflammatory liver diseases. (Hepatology HEPATOLOGY 2018;67:232-246).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Zhang H, Lian M, Zhang J, et al. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation. Hepatology. 2017. PMID: 28777871. doi:10.1002/hep.29418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。